Advertisement

Significance of Steroid Receptor Immunoassay in Breast Cancer

  • Edward J. Keenan
  • Debra Corbin

Abstract

Human breast cancers that contain estrogen (ER) and progesterone (PR) receptors are more likely to respond to antihormone therapy than are carcinomas that lack steroid receptors (1–10). This difference proviDe S the basis for the present use of ER and PR assays in determining the endocrine dependence of breast cancers (8–11). The absence of steroid receptors in breast carcinoma tissue is also of prognostic significance in that receptor-negative tumors generally recur more quickly (12–14).

Keywords

Breast Cancer Estrogen Receptor Progesterone Receptor Human Breast Cancer Primary Breast Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    E.V. Jensen, G.E. Block, S. Smith, K. Kyser, and E.R. De Sombre, Estrogen receptors and breast cancer response to adrenalectomy, Natl Cancer Inst Monograph 34:55–70, (1971).Google Scholar
  2. 2.
    H. Maass, B. Engel, H. Hohmeister, F. Lehmann, and G. Trams, Estrogen receptors in human breast cancer tissue, Am J Obstet Gynecol 113:377–382, (1972).PubMedGoogle Scholar
  3. 3.
    E. Engelsman, J.P. Persijn, C.B. Korsten, and F.J. Cleton, Oestrogen receptors in human breast cancer tissue and response to endocrine therapy, Br Med J 2:750–752, (1973).PubMedCrossRefGoogle Scholar
  4. 4.
    B.S. Leung, W.S. Fletcher, T.D. Lindel, D.C. Wood, and W.W. Krippaehne, Pedictability of response to endocrine ablation in advanced breast carcinoma, Arch Surg 106:515–519, (1973).PubMedCrossRefGoogle Scholar
  5. 5.
    E.D. Savlov, J.L. Wittliff, R. Hilf, and T.C. Hall, Correlations between certain biochemical properties of breast cancer and response to therapy: A preliminary report, Cancer 33:303–309, (1974).PubMedCrossRefGoogle Scholar
  6. 6.
    W.L. Mc Guire, P.P. Carbone, and E.P. Vollmer (eds.), “Estrogen Receptors in Human Breast Cancer”, Raven Press, New York (1975).Google Scholar
  7. 7.
    C.K. Osborne, M.G. Yochmowitz, W.A. Knight III, W.L. Mc Guire, The value of estrogen and progesterone receptors in the treatment of breast cancer, Cancer 46:2884–2888, (1980).PubMedCrossRefGoogle Scholar
  8. 8.
    K. Seibert, M. Lippman, Hormone receptors in breast cancer, Clinics in Oncology 1:735–794, (1982).Google Scholar
  9. 9.
    J.L. Wittliff, Steroid hormone receptors in breast cancer, Cancer 53:630–643, (1984).PubMedCrossRefGoogle Scholar
  10. 10.
    E.R. De Sombre, P.P. Carbone, E.V. Jensen, W.L. Mc Guire, S.A. Wells Jr., J.L. Wittliff, and M.B. Lipsett, Steroid receptors in breast cancer, N Engl J Med 301:1011–1012, (1979).CrossRefGoogle Scholar
  11. 11.
    W.L. Mc Guire and G.M. Clark, Role of progesterone receptors in breast cancer, Seminars in Oncology 12:12–16, (1985).PubMedGoogle Scholar
  12. 12.
    W.A. Knight, R.B. Livingston, E.J. Gregory, and W.L. Mc Guire, Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer, Cancer Res 37:4669–4671, (1977).PubMedGoogle Scholar
  13. 13.
    P.V. Maynard, R.W. Blamey, C.W. Elston, J.L. Haybittle, and K. Griffiths, Estrogen receptor assay in primary breast cancer and early recurrence of the disease, Cancer Res 38:4292–4295, (1978).PubMedGoogle Scholar
  14. 14.
    R. Hahnel, T. Woodings, and A.B. Vivian, Prognostic value of estrogen receptors in primary breast cancer, Cancer 44:671–675, (1979).PubMedCrossRefGoogle Scholar
  15. 15.
    J.H. Clark and E.J. Peck, “Female Sex Steroids: Receptors and Function”, Springer-Verlag, New York (1979).Google Scholar
  16. 16.
    G.L. Greene, C. Nolan, J.P. Engler, and E.V. Jensen, Monoclonal antibodies as probes for estrogen receptor detection and characterization, J Steroid Biochem 16:353–359, (1982).PubMedCrossRefGoogle Scholar
  17. 17.
    G.L. Greene, C. Nolan, J.P. Engler, and E.V. Jensen, Monoclonal antibodies to human estrogen receptor, Proc Natl Acad Sci, U.S.A., 77:5115–5119, (1980).CrossRefGoogle Scholar
  18. 18.
    G.L. Greene, F.W. Fitch, and E.V. Jensen, Monoclonal antibodies to estrophilin: Probes for the study of estrogen receptors, Proc Natl Acad Sci, U.S.A., 77:157–161, (1980).PubMedCrossRefGoogle Scholar
  19. 19.
    G.L. Greene, N.B. Sobel, W.J. King, and E.V. Jensen, Immunochemical studies of estrogen receptors, J Steroid Biochem 20:51–56, (1984).PubMedCrossRefGoogle Scholar
  20. 20.
    W.J. King, E.R. De Sombre, E.V. Jensen, and G.L. Greene, A comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors, Cancer Res 45:293–304, (1985).PubMedGoogle Scholar
  21. 21.
    L.P. Pertshuk, K.B. Eisenberg, A.C. Carter, and J.G. Feldman, Immunohistologic localization of estrogen receptors in breast cancer with monoclonal antibodies, Cancer 55:1513–1518, (1985).CrossRefGoogle Scholar
  22. 22.
    K.S. McCarty Jr., L.S. Miller, E.B. Cox, J. Konrath, and K.S. McCarty Sr., Estrogen receptor analysis. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 109:716–721, (1985).PubMedGoogle Scholar
  23. 23.
    E.R. De Sombre, S.M. Thorpe, C. Rose, R.R. Blough, K.W. Andersen, B.B. Rasmussen, and W.J. King, Prognostic usefullness of estrogen receptor immunocytochemical assays for human breast cancer, Cancer Res 46:4256–4264, (1986).Google Scholar
  24. 24.
    C. Nolan, L.W. Przywara, L.S. Miller, V. Suduikis, and J.T. Tomita, A sensitive solid-phase enzyme immunoassay for human estrogen receptor, in: “Current Controversies in Breast Cancer” F.C. Ames, G.R. Blumenschein and E.D. Montague, eds., University of Texas Press, Austin (1984).Google Scholar
  25. 25.
    V.C. Jordon, H.I. Jacobson, and E.J. Keenan, Determination of estrogen receptor in breast cancer using monoclonal antibody technology: Results of a multicenter study in the United States, Cancer Res 46:4237s–4240s, (1986).Google Scholar
  26. 26.
    M.J. Duffy, L. O’Slorain, B. Waldron, and C.Smith, Estradiol receptors in human breast carcinomas assayed by use of monoclonal antibodies, Clin Chem 32:1972–1974, (1986).PubMedGoogle Scholar
  27. 27.
    J.A. Holt and J. Bolanos, Enzyme-linked immunochemical measurement of estrogen receptor in gynecologic tumors, and an overview of steroid receptors in ovarian carcinoma, Clin Chem 32:1836–1843, (1986).PubMedGoogle Scholar
  28. 28.
    S.M. Thorpe, Monoclonal antibody technique for detection of estrogen receptors in human breast cancer: Greater sensitivity and more accurate classification of receptor status than the dextran-coated charcoal method, Cancer Res 47:6572–6575, (1987) .PubMedGoogle Scholar
  29. 29.
    C.M. Smyth, D.E. Benn, and T.S. Reeve, An enzyme immunoassay compared with a ligand-binding assay for measuring progesterone receptors in cytosols from breast cancers, Clin Chem 34: 1116–1118, (1988) .PubMedGoogle Scholar
  30. 30.
    J.T. Wu and L.W. Wilson, Progesterone receptor: Stability studies and correlation between steroid binding assay and enzyme immunoassay, Clin Chem 34:1987–1991, (1988).PubMedGoogle Scholar
  31. 31.
    S. .M. Thorpe, Immunological quantitation of nuclear receptors in human breast cancer: Relation to cytosolic estrogen and progesterone receptors, Cancer Res 47:1830–1835, (1987) .PubMedGoogle Scholar
  32. 32.
    B.G. Mobbs and I.E. Johnson, Use of an enzymeimmunoassay (EIA) for quantitation of cytosolic and nuclear estrogen receptor, and correlation with progesterone receptor in human breast cancer, J Steroid Biochem 28:653–662, (1987) .PubMedCrossRefGoogle Scholar
  33. 33.
    O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall, Protein measurement with the Folin phenol reagent, J Biol Chem 193:265–275, (1951).PubMedGoogle Scholar
  34. 34.
    . G. Scatchard, The attractions of proteins for small molecules and ions, Ann NY Acad Sci 51:660–672, (1949) .CrossRefGoogle Scholar
  35. 35.
    E.R. Barrack and D.S. Coffey, Biological properties of the nuclear matrix: Steroid hormone binding, Recent Prog Horm Res 38:133–195, (1982).PubMedGoogle Scholar
  36. 36.
    M.R. Walters, Steroid hormone receptors and the nucleus, Endocrine Rev 6 :512–543, (1985) .CrossRefGoogle Scholar
  37. 37.
    M. Nakao, B. Sato, M. Koga, K. Noma, S. Kishimoto, and K. Matsumoto, Identification of immunoassayable estrogen receptor lacking hormone binding ability in tamoxifentreated rat uterus, Biochem and Biophys Res Comm 132: 336–342, (1985) .CrossRefGoogle Scholar
  38. 38.
    P.M. Martin, Y. Berthois, and E.V. Jensen, Binding of antiestrogens exposes an occult antigenic determinant in the human estrogen receptor, Proc Natl Acad Sci, U.S .A. , 85 : 2533–2537, (1988) .PubMedCrossRefGoogle Scholar
  39. 39.
    R.F. Pommier, E.A. Woltering, E.J. Keenan, and W.S . Fletcher, The mechanism of hormone-sensitive breast cancer progression on antiestrogen therapy, Arch Surg 122 : 1311–1316, (1987) .PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • Edward J. Keenan
    • 1
  • Debra Corbin
    • 1
  1. 1.Departments of Pharmacology, Surgery, and Medicine School of MedicineThe Oregon Health Sciences UniversityPortlandUSA

Personalised recommendations